Kane Biotech Inc. (TSXV:KNE)
0.0300
0.00 (0.00%)
Nov 20, 2026, 11:52 AM EST
Kane Biotech Market Cap
Kane Biotech has a market cap or net worth of CAD 6.15 million as of November 20, 2026. It is the 45,257th most valuable company in the world and the 1,736th biggest in Canada. Its market cap has increased by 5.03% in one year.
Market Cap
6.15M
Enterprise Value
7.26M
Revenue
38.72K
Global Rank
Country Rank
#1,736 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since May 20, 2003, Kane Biotech's market cap has increased from 1.03M to 6.15M, an increase of 498.24%. That is a compound annual growth rate of 7.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 6.15M | -15.31% |
| Dec 30, 2025 | 7.26M | -51.98% |
| Dec 31, 2024 | 15.13M | 43.41% |
| Dec 29, 2023 | 10.55M | -6.12% |
| Dec 30, 2022 | 11.23M | -36.87% |
| Dec 31, 2021 | 17.80M | 17.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Onco-Innovations | 9.69M |
| Marvel Biosciences | 8.49M |
| COSCIENS Biopharma | 8.19M |
| Glow Lifetech | 7.70M |
| Hemostemix | 7.40M |
| Rakovina Therapeutics | 7.36M |
| MYND Life Sciences | 5.22M |
| Restart Life Sciences | 4.06M |